Your browser doesn't support javascript.
loading
Prevalence and Factors Associated With Statin Use Among Patients With Nonalcoholic Fatty Liver Disease in the TARGET-NASH Study.
Thomson, Mary J; Serper, Marina; Khungar, Vandana; Weiss, L Michael; Trinh, Huy; Firpi-Morell, Roberto; Roden, Michael; Loomba, Rohit; Barritt, A Sidney; Gazis, Derek; Mospan, Andrea R; Fried, Michael W; Reddy, K Rajender; Lok, Anna S.
Afiliación
  • Thomson MJ; Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolis, Minnesota.
  • Serper M; Division of Gastroenterology and Hepatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
  • Khungar V; Division of Gastroenterology and Hepatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
  • Weiss LM; Gastro Florida, Clearwater, Florida.
  • Trinh H; San Jose Gastroenterology, San Jose, California.
  • Firpi-Morell R; Division of Gastroenterology, Hepatology and Nutrition, University of Florida, Gainesville, Florida.
  • Roden M; Department of Endocrinology and Diabetology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany; Institute for Clinical Diabetology, German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich-Heine University, Düsseldorf, Ge
  • Loomba R; Division of Gastroenterology, Department of Medicine, University of California San Diego, La Jolla, California.
  • Barritt AS; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Gazis D; Target RWE, Durham, North Carolina.
  • Mospan AR; Target RWE, Durham, North Carolina.
  • Fried MW; Target RWE, Durham, North Carolina.
  • Reddy KR; Division of Gastroenterology and Hepatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
  • Lok AS; Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan. Electronic address: aslok@med.umich.edu.
Clin Gastroenterol Hepatol ; 20(2): 458-460.e4, 2022 02.
Article en En | MEDLINE | ID: mdl-33775894
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Hidroximetilglutaril-CoA Reductasas / Enfermedad del Hígado Graso no Alcohólico / Neoplasias Hepáticas Tipo de estudio: Prevalence_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Gastroenterol Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Hidroximetilglutaril-CoA Reductasas / Enfermedad del Hígado Graso no Alcohólico / Neoplasias Hepáticas Tipo de estudio: Prevalence_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Gastroenterol Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos